Name: Return on Assets (ROA)

Definition: ROA shows how efficiently the company turns everything it owns — its entire asset base — into net profit after all costs and taxes. A higher ROA means the business squeezes more profit from its assets. Lower ROA might reflect poor asset utilization or heavy reliance on expensive financing.

Interpretation:
• In '2021', ABSI's return on assets was -23.7%, representing returns generated from total assets. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2021' stood at -96.4%.
• In '2022', ABSI's return on assets was -28.1%, representing returns generated from total assets. The decline from '2021' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2022' stood at -22.5%. Industry average increased by 73.8% compared to previous year.
• In '2023', ABSI's return on assets was -41.1%, representing returns generated from total assets. The decline from '2022' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2023' stood at -16.8%. Industry average increased by 5.8% compared to previous year.
• In '2024', ABSI's return on assets was -47.9%, representing returns generated from total assets. The decline from '2023' may indicate some operational or financial challenges. Industry average for Biotechnology: Commercial Physical & Biological Resarch in '2024' stood at -85.8%. Industry average declined by 69.0% from previous year.
Overall, ABSI's return on assets has been volatile but showed a downward trend over the past 4 years.

Formula: ROA = Net Income / Total Assets

Good Range: Commonly 5%-15%.